Human Cells Enable Beating Hearts in Pig Embryos
Researchers have engineered pig embryos by knocking out heart-development genes and introducing modified human stem cells. The pig–human chimeras survived 21 days, during which tiny human‑cell‑derived hearts began beating. This work was presented at the International Society for Stem Cell Research meeting in Hong Kong. The human cells were genetically enhanced to resist death and promote growth, while pig embryos were gene-edited to lack key heart-forming functions. Though embryos collapsed after three weeks—likely due to developmental incompatibilities—the study paves a path toward lab-growing transplantable human organs in animals. Ethical issues and biological hurdles remain a challenge. (Nature)
Medicaid Data Shared with DHS Sparks Legal Concern
An AP News investigation uncovered that the Trump administration directed the Centers for Medicare and Medicaid Services (CMS) to transfer personal data—including immigration status, names, addresses, SSNs, and claims—for millions of Medicaid enrollees in California, Illinois, Washington, and D.C. to the Department of Homeland Security (DHS). CMS staff privately protested, citing violations of the Social Security Act and Privacy Act, but were ordered to comply within 54 minutes. Critics argue the transfer could facilitate deportations and deter immigrants from seeking care. State officials labeled the move potentially unlawful and warned of eroded public trust. The administration defends it as preventing misuse of federal funds. (AP)
Ex‑Surgeon General: Vaccine Panel Purge Sets Troubling Precedent
Former U.S. Surgeon General Jerome Adams criticized the abrupt dismissal of all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP). Adams warns the move, ordered by Health Secretary RFK Jr., undermines over six decades of evidence-based, transparent vaccine policy. He fears it sets a dangerous precedent, especially as insiders question whether RFK misrepresented his intentions to preserve vaccine funding. Adams contends the overhaul threatens the integrity of U.S. public health infrastructure and could damage vaccine confidence. (Axios)
Post‑Dengue Patients Face Elevated Organ Risks, Hospitalization, DeathA study in Clinical Microbiology and Infection analyzed 55,870 Singaporean adults with dengue (2017–2023) versus 3.1 million controls. It found dengue survivors had a 22 % higher risk of hospitalization (HR 1.22) and double the risk of death (HR 2.08) during 31–300 days post‑infection. The likelihood of new multi‑organ complications increased over time. Older adults (≥61), men, those with underlying conditions, or infected by DENV‑2/3 serotypes were especially vulnerable. The study highlights dengue’s long-term health burden beyond its acute phase, underscoring the need for follow-up care in endemic regions. (CIDRAP)
Report Says U.S. Biofuels Policy May Worsen Emissions
A new analysis highlights that corn and soy-based biofuel mandates in the U.S. might actually increase greenhouse gas emissions. The findings are aligned with broader concerns that diverting land for biofuel crops drives deforestation, fertilizer use, and fuel-intensive agriculture—offsetting intended climate benefits. The report warns current policy frameworks may be misleading the public and policymakers. It urges comprehensive assessments that factor in indirect land-use change and full lifecycle emissions before expanding biofuel programs. (Ars Technica)
Illinois Faces Data-Center Water Strain as Expansion Grows
Inside Climate News reports that Illinois, a major data-center hub, is ramping up construction of new facilities. These centers consume substantial water—for cooling and power generation—which compounds pressure on local water supplies, especially during droughts. One suburb has already approved one complex and is considering two more. Officials, utilities, and residents are already seeing higher electricity and water demands. The article suggests policymakers should integrate data-center water impact into planning, balancing economic benefits with sustainable resource use. (Inside Climate News)
J&J’s CAR‑T Shows 100 % Initial Response in Lymphoma Trial
Johnson & Johnson reported interim Phase 1b data for their CAR‑T therapy in relapsed/refractory large B-cell lymphoma. Among 10 patients with one prior therapy, the objective response rate (ORR) was 100%, with 8 achieving complete remission. In a broader 22-patient cohort, ORR reached 92% and complete response rate was 75%. However, 84% experienced grade 3–4 adverse events; 28% were serious. Results come from a 25-patient safety arm. While efficacy signs are strong, J&J notes careful monitoring is needed given the toxicity observed. (Fierce Biotech)
Experimental Obesity Pill Burns Fat Without Reducing Appetite
A novel obesity pill, SANA, from Uruguay-based Eolo Pharma, promotes fat burning through activation of creatine-dependent thermogenesis. In a Phase I trial, participants lost ~3 % body weight over two weeks without suppressing appetite—a departure from GLP‑1 drugs like Ozempic. Derived from salicylate, SANA also maintained muscle mass in animal studies. It works directly on cells to increase energy expenditure and showed good tolerability. A larger U.S. Phase II trial (~100 participants) is planned for late 2025. Experts welcome the metabolic approach as a promising alternative or complement to appetite-suppressant therapies. (Wired)
Viking Woman Buried with Beloved Dog in Rare Boat Grave
Archaeologists from the Arctic University Museum of Norway uncovered a 10th-century Viking boat grave on Senja island containing an elite woman buried with her dog. The burial included ornate brooches, beads, and tools linked to Viking womanhood, helping date the grave to 900–950 CE. The careful placement of the dog at her feet reflects a deep bond, suggesting that women, like men, held strong emotional connections to their pets over a millennium ago. The 17.7-foot-long boat and high-status grave goods confirm the woman’s elite standing. Ongoing analysis in Tromsø will reveal more about her life, while another brooch nearby raises hopes for a second grave. The discovery offers rare insight into Viking burial customs and human-animal companionship. (Gizmodo)
Sukunaarchaeum: A Microbe That Blurs the Line Between Life and Virus
Scientists have discovered a mysterious microbe, provisionally named Sukunaarchaeum, which behaves like a virus but is classified as an archaeon. Found inside Citharistes regius, a marine dinoflagellate, its genome is only 238,000 base pairs long—remarkably small—and nearly all of its 189 genes are dedicated to replicating itself. Lacking nearly all metabolic pathways, it depends entirely on its host for survival. Yet unlike viruses, it can independently replicate its DNA. Researchers suggest it may represent an evolutionary intermediate between cellular life and viruses. Its widespread DNA signature in seawater points to an undiscovered lineage. Scientists now aim to visualize the microbe and understand its biology, which may offer rare insights into viral evolution and the origins of life’s complexity. (Science)
Thanks for reading. Let’s be careful out there.
WORDS: The Biology Guy.
Leave a Reply